Efficacy of Sildenafil on the Morbi-mortality of Peripheral Arterial Diseased Patients With Intermittent Claudication

Stopped The Investigator-Coordinator has moved to Rennes University Hospital. It will be done under the sponsor of Rennes University Hospital : NCT03686306

Conditions

• Peripheral Arterial Occlusive Disease

Interventions

• DRUG: Sildenafil 100 mg oral morning dose
• DRUG: Placebo oral morning dose

Sponsor

University Hospital, Angers